Effect of teduglutide, a glucagon-like peptide-2 analog, in eosinophilic enterocolitis: a case report

被引：0

作者：

Ogawa, Shoko ^{[1
]}

Konishi, Ken-ichiro ^{[1
]}

Tanaka, Kiyoshi ^{[2
]}

Takayasu, Hajime ^{[1
]}

Uematsu, Yoshimasa ^{[1
]}

Ito, Takashi ^{[3
]}

Takahashi, Hiroyuki ^{[4
]}

Kumamoto, Yusuke ^{[1
]}

机构：

[1] Kitasato Univ, Sch Med, Dept Gen Pediat & Hepatobiliary Pancreat Surg, Sagamihara, Kanagawa, Japan

[2] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Dept Adv Med,Div Pediat Surg, Sagamihara, Kanagawa, Japan

[3] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan

[4] Kitasato Univ, Sch Allied Hlth Sci, Dept Pathol, Sagamihara, Kanagawa, Japan

来源：

FRONTIERS IN PEDIATRICS | 2024年 / 12卷

关键词：

glucagon-like peptide-2 analog; immune effect; short bowel syndrome; eosinophilic gastrointestinal diseases; teduglutide; COWS MILK ALLERGY; ANTIINFLAMMATORY ACTIONS; INFLAMMATION; PATHWAYS; BARRIER;

D O I：

10.3389/fped.2024.1457824

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

We successfully treated a 4-year-old girl with short bowel syndrome and eosinophilic enterocolitis with teduglutide, a glucagon-like peptide-2 analog. Her eosinophilic enterocolitis was cured without relapse, and we were able to increase enteral nutrition. We found that teduglutide had an anti-inflammatory effect in this patient with eosinophilic gastrointestinal disease associated with short bowel syndrome. This report is the first to describe use of teduglutide in the treatment of eosinophilic gastrointestinal disease.

引用

页数：5

共 50 条

[41] Plasma glucagon-like peptide-2 in cats with chronic enteropathies
Jugan, Maria C.
Plattner, Brandon L.
Ford, Alexandra K.
Freilich, Leah
Bieberly, Zackery
Schermerhorn, Thomas
JOURNAL OF FELINE MEDICINE AND SURGERY, 2025, 27 (01)
[42] Current and potential therapeutic targets of glucagon-like peptide-2
Austin, Kaori
Markovic, Melanie A.
Brubaker, Patricia L.
CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 13 - 18
[43] Structure, measurement, and secretion of human glucagon-like peptide-2
Hartmann, B
Johnsen, AH
Orskov, C
Adelhorst, K
Thim, L
Holst, JJ
PEPTIDES, 2000, 21 (01) : 73 - 80
[44] Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
Yusta, Bernardo
Matthews, Dianne
Koehler, Jacqueline A.
Pujadas, Gemma
Kaur, Kiran Deep
Drucker, Daniel J.
ENDOCRINOLOGY, 2019, 160 (08) : 1950 - 1963
[45] The effects of glucagon-like peptide-2 on peripheral blood vessels
Tsuneoka, Yayoi
Nishimura, Tsubasa
Masuhuchi, Ryotaro
Oka, Jun-Ichiro
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S202 - S202
[46] Biologic properties and therapeutic potential of glucagon-like peptide-2
Drucker, DJ
Boushey, RP
Wang, F
Hill, ME
Brubaker, PL
Yusta, B
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (05) : S98 - S100
[47] Glucagon-like peptide-2: Update of the recent clinical trials
Jeppesen, PB
GASTROENTEROLOGY, 2006, 130 (02) : S127 - S131
[48] Effect of the semisynthetic form of glucagon-like peptide-2 analog in an experimental model of intestinal ischemia-reperfusion injury
Moreira, Jeremias E.
Stringa, Pablo
Gentilini, Maria Virginia
Arriola, Constanza
Ivanoff, Ivana
Rumbo, Martin
Gondolesi, Gabriel E.
JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 28 (07) : 1169 - 1171
[49] The protective and anti-inflammatory effects of glucagon-like peptide-2 in an experimental rat model of necrotizing enterocolitis
Nakame, Kazuhiko
Kaji, Tatsuru
Mukai, Motoi
Shinyama, Shin
Matsufuji, Hiroshi
PEPTIDES, 2016, 75 : 1 - 7
[50] Teduglutide, a glucagon-like peptide-2 (GLP-2) analog, improves fluid balance in short bowel syndrome (SBS) patients depending on parenteral support (PN)
Jeppesen, Palle B.
Messing, Bernard
Pertkiewicz, Marek
Cyran, Jane
Demchyshyn, Lidia L.
Kershner, Ronald
GASTROENTEROLOGY, 2008, 134 (04) : A110 - A111

← 1 2 3 4 5 →